Larynx Clinical Trials

25 recruitingLast updated: May 13, 2026

There are 25 actively recruiting larynx clinical trials across 14 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Early Phase 1. Top locations include Houston, Texas, United States, New York, New York, United States, Columbus, Ohio, United States. Updated daily from ClinicalTrials.gov.


Larynx Trials at a Glance

25 actively recruiting trials for larynx are listed on ClinicalTrialsFinder across 6 cities in 14 countries. The largest study group is Not Applicable with 10 trials, with the heaviest enrollment activity in Houston, New York, and Columbus. Lead sponsors running larynx studies include University of Erlangen-Nürnberg Medical School, Vanderbilt-Ingram Cancer Center, and Centre Leon Berard.

Browse larynx trials by phase

Treatments under study

About Larynx Clinical Trials

Looking for clinical trials for Larynx? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Larynx trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Larynx clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 25 trials

Recruiting
Not Applicable

High-Resolution PET-CT Imaging for Surgical Margin Visualization

CancerHNSCCSCC - Squamous Cell Carcinoma+2 more
Vanderbilt-Ingram Cancer Center50 enrolled1 locationNCT06915454
Recruiting
Early Phase 1

Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer

HNSCCSCC - Squamous Cell CarcinomaHNSCC,Larynx, Pharynx and Oral Cavity
Vanderbilt-Ingram Cancer Center18 enrolled1 locationNCT06819228
Recruiting
Phase 3

Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma

Oropharynx CancerLarynx CancerHypopharynx Cancer+1 more
Centre Leon Berard460 enrolled8 locationsNCT06706401
Recruiting
Phase 1

Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

Malignant Neoplasms of Respiratory and Intrathoracic OrgansSquamous Cell Carcinoma of the Larynx
M.D. Anderson Cancer Center11 enrolled1 locationNCT03114462
Recruiting
Phase 2

First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients

Head & Neck CancerMetastatic Squamous Cell CarcinomaOropharynx Squamous Cell Carcinoma+3 more
Wake Forest University Health Sciences32 enrolled1 locationNCT04858269
Recruiting

Immune Biomarker Study for Cisplatin-ineligible Patients Receiving Chemoradiotherapy With Docetaxel

Squamous Cell Carcinoma of OropharynxOral Cavity Squamous Cell CarcinomaLarynx Squamous Cell Carcinoma+1 more
University of Erlangen-Nürnberg Medical School250 enrolled1 locationNCT06947668
Recruiting
Phase 2Phase 3

De-Intensification of Postoperative Radiotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck

Squamous Cell Carcinoma of the LarynxSquamous Cell Carcinoma of the OropharynxSquamous Cell Carcinoma of the Oral Cavity+1 more
University of Erlangen-Nürnberg Medical School508 enrolled1 locationNCT06030440
Recruiting
Phase 2

A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)

Squamous Cell Carcinoma of Head and NeckOral Cavity CancerNasal Cavity Cancer+9 more
Memorial Sloan Kettering Cancer Center40 enrolled7 locationsNCT07063212
Recruiting
Not Applicable

Predicting Post Extubation Stridor After Maxillomandibular Fixation

StridorLarynx Edema
Mansoura University62 enrolled1 locationNCT05839756
Recruiting
Not Applicable

Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck

Tongue CancerRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Mucoepidermoid Carcinoma of the Oral Cavity+48 more
Ohio State University Comprehensive Cancer Center600 enrolled1 locationNCT01473784
Recruiting
Not Applicable

CONFIRM: Magnetic Resonance Guided Radiation Therapy

Gastric CancerIn Situ Breast CancerInvasive Breast Cancer+3 more
Brigham and Women's Hospital70 enrolled2 locationsNCT04368702
Recruiting
Not Applicable

Accuracy of the Sensory Test Using the Laryngopharyngeal Endoscopic Esthesiometer in Obstructive Sleep Apnea

Sensory DisorderSleep Apnea, ObstructiveLarynx
Fundación Neumologica Colombiana117 enrolled2 locationsNCT03109171
Recruiting
Phase 1Phase 2

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Esophageal CancerPancreatic CancerHead and Neck Squamous Cell Carcinoma (HNSCC)+22 more
VM Oncology, LLC242 enrolled15 locationsNCT03556228
Recruiting
Not Applicable

Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy

Head and Neck CancerHead and Neck Squamous Cell CarcinomaOral Cavity Cancer+2 more
Medical University of South Carolina532 enrolled4 locationsNCT05793151
Recruiting

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Breast CancerOvarian CancerEndometrial Cancer+40 more
Massive Bio, Inc.50,000 enrolled68 locationsNCT03452774
Recruiting
Not Applicable

VoiceS: Voice Quality After Transoral CO2-Laser Surgery Versus Single Vocal Cord Irradiation for Larynx Cancer

Glottis TumorLarynx Cancer
Olgun Elicin34 enrolled4 locationsNCT04057209
Recruiting
Not Applicable

Proactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck Cancer

Oral Cancer , Oral Squamous Cell Carcinoma, Oral Cavity CancerHead &Amp;Amp; Neck Squamous Cell CarcinomaLarynx Squamous Cell Carcinoma
Centre hospitalier de l'Université de Montréal (CHUM)85 enrolled1 locationNCT07180901
Recruiting
Phase 1Phase 2

RAPA-201 Therapy of Solid Tumors

Head and Neck CancerEsophageal Squamous Cell CarcinomaSolid Tumor+6 more
Rapa Therapeutics LLC37 enrolled1 locationNCT05144698
Recruiting

Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy

HNSCCOral Cavity CancerOropharynx Cancer+2 more
University Hospital Freiburg1,500 enrolled18 locationsNCT05337631
Recruiting

Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome

Squamous Cell Carcinoma of the LarynxSquamous Cell Carcinoma of the OropharynxSquamous Cell Carcinoma of the Oral Cavity+1 more
AIO-Studien-gGmbH120 enrolled2 locationsNCT06380686